Key references: Prevalence and natural history of NAFLD

  • Adams LA, Roberts SK, Strasser SI, Mahady SE, Powell E, Estes C, et al. Nonalcoholic fatty liver disease burden: Australia, 2019-2030. J Gastroenterol Hepatol 2020. https://www.ncbi.nlm.nih.gov/pubmed/32048317
  • Calzadilla-Bertot L, Jeffrey GP, Jacques B, McCaughan G, Crawford M, Angus P, et al. Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand. Liver Transpl 2019;25(1):25–34. https://www.ncbi.nlm.nih.gov/pubmed/30609187
  • Deloitte Access Economics2013. https://www.gesa.org.au/resources/economic-cost-and-health-burden-of-liver-disease-in-australia/
  • Huang RC, Beilin LJ, Ayonrinde O, Mori TA, Olynyk JK, Burrows S, et al. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology 2013;58(4):1306–14. https://www.ncbi.nlm.nih.gov/pubmed/23703776
  • Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013;57(4):1357–65. https://www.ncbi.nlm.nih.gov/pubmed/23175136
  • Koehler EM, Plompen EP, Schouten JN, Hansen BE, Darwish Murad S, Taimr P, et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study. Hepatology 2016;63(1):138–47. https://www.ncbi.nlm.nih.gov/pubmed/26171685
  • McCaughan GW, Munn SR. Liver transplantation in Australia and New Zealand. Liver Transpl 2016;22(6):830–8. https://www.ncbi.nlm.nih.gov/pubmed/27028552
  • Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 2015;13(4):643-54 e1-9; quiz e39-40. https://www.ncbi.nlm.nih.gov/pubmed/24768810
  • Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, et al. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017 - Part 1: definition, risk factors and assessment. J Gastroenterol Hepatol 2018;33(1):70–85. https://www.ncbi.nlm.nih.gov/pubmed/28670712
  • Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease - meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64(1):73–84. https://www.ncbi.nlm.nih.gov/pubmed/26707365